During the past decade, Yokohama Minoru Clinic conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yokohama Minoru Clinic" are "Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus" (1 trials), "Hypercholesterolemia" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Yokohama Minoru Clinic" in a lesser frequency.

Most popular intervention types in "Yokohama Minoru Clinic" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Tirzepatide" (3 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "23-valent pneumococcal polysaccharide vaccine" (1 trials) and "Bococizumab (PF-04950615;RN316)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yokohama Minoru Clinic" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Yokohama Minoru Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Yokohama Minoru Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yokohama Minoru Clinic, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".